|
WO2019164984A1
|
|
Topical compositions with stable solubilized selective retinoids and/or tetracycline-class antibiotics
|
|
US2020129495A1
|
|
Ebastine topical composition
|
|
US2018318342A1
|
|
Magnesium chloride composition for dermatological use
|
|
US2017304359A1
|
|
Oral iodine dosage form
|
|
US2016287615A1
|
|
Novel encapsulation of fluorescent, photo-sensitive, or oxygen-sensitive active ingredient for topical application
|
|
CN107708665A
|
|
Medicinal Fourth Ring promotor composition for dermatological use
|
|
US2015147400A1
|
|
Solid oral dosage form for breast symptoms
|
|
US2015125496A1
|
|
Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
|
